guselkumab
janssen
['ulcerative colitis', 'guselkumab']
during the late breaker session at #ddw23, said guselkumab 200 mg iv induction was safe and effective in the treatment of patients with moderate to severely active ulcerative colitis compared to placebo. #gitwitter #medtwitter
The content you need, when you need it.